In October 2007, the FDA introduced the labeling for all PDE5 inhibitors, including tadalafil, requires a more prominent warning of your likely threat of unexpected hearing reduction as the results of write-up-advertising studies of short term deafness associated with utilization of PDE5 inhibitors.[19]Although Cialis doesn’t change the measureme